NCT06976320 Deep Rectus Sheath Block for Laparoscopic Cholecystectomy
| NCT ID | NCT06976320 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istinye University |
| Condition | Cholecystectomy, Laparoscopic |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-09-09 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-09-09 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postoperative pain after laparoscopic cholecystectomy can be considerable. Regional techniques such as erector spinae plane (ESP) block or transversus abdominis plane (TAP) block may be suitable for patients at increased risk of postoperative pain. The deep rectus sheath block is a novel block which is a modified version of the conventional rectus sheath block. It was reported in a few case reports that, it may be used for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. The aim of this study is to investigate the postoperative analgesic efficacy of deep rectus sheath block in patients undergoing laparoscopic cholecystectomy.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 80 years * Patients with American Society of Anesthesiology (ASA) physical status I-II * Patients scheduled for a laparoscopic cholecystectomy Exclusion Criteria: * Allergy to local anesthetics * Coagulopathy * Skin infection at the deep rectus sheath block area * Advanced hepatic or renal failure * Chronic pain syndromes * Alcohol or drug abuse * Severe pulmonary and/or cardiovascular disease * Psychiatric disorders
Contact & Investigator
Taylan Sahin, M.D.
PRINCIPAL INVESTIGATOR
Istinye University
Frequently Asked Questions
Who can join the NCT06976320 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cholecystectomy, Laparoscopic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06976320 currently recruiting?
Yes, NCT06976320 is actively recruiting participants. Contact the research team at taylansah@hotmail.com for enrollment information.
Where is the NCT06976320 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06976320 clinical trial?
NCT06976320 is sponsored by Istinye University. The principal investigator is Taylan Sahin, M.D. at Istinye University. The trial plans to enroll 60 participants.